HK1147057A1 - Medicament and formulations thereof for use in reducing or preventing atherosclerosis - Google Patents

Medicament and formulations thereof for use in reducing or preventing atherosclerosis

Info

Publication number
HK1147057A1
HK1147057A1 HK11101117.3A HK11101117A HK1147057A1 HK 1147057 A1 HK1147057 A1 HK 1147057A1 HK 11101117 A HK11101117 A HK 11101117A HK 1147057 A1 HK1147057 A1 HK 1147057A1
Authority
HK
Hong Kong
Prior art keywords
medicament
formulations
reducing
preventing atherosclerosis
molecular weight
Prior art date
Application number
HK11101117.3A
Other languages
English (en)
Inventor
Hikaru Ishii
Original Assignee
Hikaru Ishii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hikaru Ishii filed Critical Hikaru Ishii
Publication of HK1147057A1 publication Critical patent/HK1147057A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK11101117.3A 2008-05-20 2011-02-02 Medicament and formulations thereof for use in reducing or preventing atherosclerosis HK1147057A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008131621A JP2009280508A (ja) 2008-05-20 2008-05-20 血管老化抑制剤および老化防止抑制製剤
PCT/JP2009/059490 WO2009142319A1 (en) 2008-05-20 2009-05-19 Vascular aging inhibitor and anti-aging formulation

Publications (1)

Publication Number Publication Date
HK1147057A1 true HK1147057A1 (en) 2011-07-29

Family

ID=40890739

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11101117.3A HK1147057A1 (en) 2008-05-20 2011-02-02 Medicament and formulations thereof for use in reducing or preventing atherosclerosis

Country Status (13)

Country Link
US (1) US20110092432A1 (ru)
EP (1) EP2276504B1 (ru)
JP (1) JP2009280508A (ru)
KR (1) KR20110013489A (ru)
CN (1) CN102014949A (ru)
AT (1) ATE531386T1 (ru)
AU (1) AU2009250386B2 (ru)
DK (1) DK2276504T3 (ru)
ES (1) ES2374602T3 (ru)
HK (1) HK1147057A1 (ru)
RU (1) RU2455022C1 (ru)
TW (1) TWI388331B (ru)
WO (1) WO2009142319A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3058142B1 (fr) * 2016-10-28 2023-11-24 Gelatines Weishardt Composition de peptides de collagene de peau de poisson et son utilisation a titre de medicament
CN114316029B (zh) * 2022-01-27 2023-06-27 西安巨子生物基因技术股份有限公司 透皮吸收性肽及通过该肽的重复构建的重组胶原蛋白

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8812992D0 (en) * 1988-06-01 1988-07-06 Natural Resources Mfg Ltd Improvements in/relating to protein products
FR2678624A1 (fr) * 1991-07-04 1993-01-08 Coletica Utilisation de la peau non pigmentee de poisson, en particulier de poisson plat comme nouvelle source industrielle de collagene, procede d'extraction, collagene et biomateriau ainsi obtenus.
JP4236850B2 (ja) * 2002-02-15 2009-03-11 焼津水産化学工業株式会社 魚類由来のコラーゲンペプチドの製造方法並びに該製造方法により得られた魚類由来のコラーゲンペプチドを含有する飲食品及び化粧品
US20060078532A1 (en) * 2004-10-12 2006-04-13 Omoigui Osemwota S Method of prevention and treatment of Atherosclerosis, Peripheral vascular disease, Coronary artery disease, aging and age-related disorders including osteoporosis, arthritis, type 2 diabetes, dementia and Alzheimer's disease
JP4301100B2 (ja) * 2004-07-21 2009-07-22 セイコーエプソン株式会社 レイアウト要素の配置装置、レイアウト要素の配置方法、及びレイアウト要素の配置プログラム
JP4253296B2 (ja) * 2004-12-16 2009-04-08 尚文 石川 健康美容食品
CN101061827B (zh) * 2006-04-30 2012-01-25 中国食品发酵工业研究院 从鱼皮、鱼骨中酶法制取鱼胶原肽的工业生产方法
CA2669524C (en) * 2006-11-15 2015-02-17 Meiji Seika Kaisha, Ltd. Collagen peptide composition and food or beverage containing the same

Also Published As

Publication number Publication date
EP2276504A1 (en) 2011-01-26
TW201000111A (en) 2010-01-01
AU2009250386A1 (en) 2009-11-26
KR20110013489A (ko) 2011-02-09
WO2009142319A1 (en) 2009-11-26
AU2009250386B2 (en) 2012-09-13
DK2276504T3 (da) 2012-02-06
ES2374602T3 (es) 2012-02-20
ATE531386T1 (de) 2011-11-15
RU2455022C1 (ru) 2012-07-10
CN102014949A (zh) 2011-04-13
EP2276504B1 (en) 2011-11-02
US20110092432A1 (en) 2011-04-21
JP2009280508A (ja) 2009-12-03
TWI388331B (zh) 2013-03-11

Similar Documents

Publication Publication Date Title
AU2016204344A1 (en) Improved methods and compositions for wound healing
WO2009074735A3 (fr) Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
MX339255B (es) Una para usarse en el rejuvenecimiento de la piel que comprende, eosina y , un oxidante y un factor cicatrizante.
WO2009034537A3 (en) Cosmetic composition comprising hydroxymethionine and 3-aminopropanesulfonic acid
WO2012003377A3 (en) Methods of preparing chorion tissue and products derived therefrom
MX2013005398A (es) Hidrolizado de colageno para usarse para mejorar la salud de la piel, el cabello y/o uñas de un humano.
WO2008147817A3 (en) Coated hyaluronic acid particles
MX2012000827A (es) Particulas que incorporan agentes antimicrobianos.
NZ595952A (en) Antimicrobial compositions and related methods of use
NZ611606A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
NZ596254A (en) Cleanser compositions and methods for using the same comprising linalool, hinokitiol, diol and surfactant
WO2008139122A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
WO2008109872A3 (en) Systems, methods, and devices for soft tissue attachment to bone
WO2011148328A3 (en) Cosmetic process for making-up and/or caring for the skin and/or the lips
MX2010006933A (es) Composiciones y metodos para reducir o prevenir la deshidratación de la piel.
MX342613B (es) Geles con base de acido hialuronico que incluyen agentes anestesicos.
NZ612533A (en) Granzyme b inhibitor compositions, methods and uses for promoting wound healing
BRPI0818481A8 (pt) Composições de gel hidroalcoólico, método de redução da formação de depósitos de gel coagulado e método de redução da frequência de saída com direções erradas de um dispensador em gel.
MX2012006629A (es) Microorganismos probioticos como agentes activos contra cambios en microrelieve de la piel.
WO2008070859A3 (en) Treatment of skin conditions by dickkopf1 (dkk1)
MX2010006650A (es) Materiales y metodos para el tratamiento de proliferacion vascular ocular patologica.
WO2008047061A3 (fr) Utilisation cosmetique par voie orale et/ou parenterale de la glucosamine eventuellement associee a au moins un compose polyphenol et composition correspondante
MX2012008890A (es) Composicion de combinacion, que comrpende como ingrediente activo l-carnitina o propionil l-carnitina, para la prevencion o tratamiento de insuficiencia venosa cronica.
MX2009003060A (es) Emulsion.
HK1147057A1 (en) Medicament and formulations thereof for use in reducing or preventing atherosclerosis